Journal
BRIEFINGS IN FUNCTIONAL GENOMICS
Volume 16, Issue 4, Pages 205-210Publisher
OXFORD UNIV PRESS
DOI: 10.1093/bfgp/elw037
Keywords
Kallmann; anosmin-1; KAL1; ANOS1; gene; nomenclature
Funding
- Spanish Ministerio de Economia y Competitividad-MINECO [SAF2012-40023, RD12-0032-12]
- Consejo Superior de Investigaciones Cientificas-CSIC [CSIC-2015201023]
- National Human Genome Research Institute [U41HG003345]
- Wellcome Trust [099129/Z/12/Z]
- Fondazione Telethon [E.523]
- Ministero dell'Istruzione Universita e Ricerca (MIUR)
- Wellcome Trust [099129/Z/12/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
It is accepted that confusion regarding the description of genetic variants occurs when researchers do not use standard nomenclature. The Human Genome Organization Gene Nomenclature Committee contacted a panel of consultants, all working on the KAL1 gene, to propose an update of the nomenclature of the gene, as there was a convention in the literature of using the KAL1' symbol, when referring to the gene, but using the name 'anosmin-1' when referring to the protein. The new name, ANOS1, reflects protein name and is more transferrable across species.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
